$4.089
0.139[3.52%]
At close: Apr 26
$4.089
0[0.00%]
After Hours: 7:55PM EDT
Novavax
(NASDAQ:NVAX)Latest News for Novavax Stock (NASDAQ:NVAX)
Novavax Stock (NASDAQ: NVAX)
Categories: All
Thursday, April 18, 2024
Monday, April 15, 2024
- What's Going On With Novavax Stock Today?Adam Eckert - Apr 15, 2024, 9:14AM
- Novavax shares are trading higher after Shah Capital Management reported a 6.66% stake in the company.Benzinga Newsdesk - Apr 15, 2024, 7:48AM
- Shah Capital Management Reported 6.66% Stake in Novavax In 13D FilingCharles Gross - Apr 15, 2024, 7:19AM
- Shah Capital Nominates Two Independent Director Candidates For NovavaxBenzinga Newsdesk - Apr 15, 2024, 6:03AM
Tuesday, April 09, 2024
Monday, April 01, 2024
Tuesday, March 26, 2024
Friday, March 15, 2024
Monday, March 11, 2024
- Novavax, Inc. Says Canada National Advisory Committee Publishes Recommendation For Use Of Novavax's Nuvaxovid XBB.1.5 Covid-19 Vaccine; Recommendations State That Nuvaxovid XBB.1.5 Can Be Used In Unvaccinated Or Previously Vaccinated Individuals Aged 12 Years And OlderBenzinga Newsdesk - Mar 11, 2024, 9:20AM
- Novavax Says Canada National Advisory Committee Publishes Recommendation For Use Of Novavax's Nuvaxovid XBB.1.5 Covid-19 Vaccine; Recommendations State That Nuvaxovid XBB.1.5 Can Be Used In Unvaccinated Or Previously Vaccinated Individuals Aged 12 Years And OlderBenzinga Newsdesk - Mar 11, 2024, 9:18AM
Friday, March 01, 2024
Thursday, February 29, 2024
Wednesday, February 28, 2024
- Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 28, 2024, 2:02PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 28, 2024, 12:31PM
- Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday?Vandana Singh - Feb 28, 2024, 10:52AM
- Novavax shares are trading lower after the company reported worse-than-expected Q4 sales results and issued Q1 revenue guidance below estimates.Benzinga Newsdesk - Feb 28, 2024, 9:07AM
- Novavax Says Total Potential Contract Value For Advance Purchase Agreement Outstanding As Of December 31, 2023 Were Over $1B Related To Expected Dose Deliveries For 2024 Through 2026Benzinga Newsdesk - Feb 28, 2024, 8:16AM
- Novavax Expects Q1 2024 Revenue Of Approximately $100M Versus Consensus Of $292.33MBenzinga Newsdesk - Feb 28, 2024, 8:13AM
- Novavax Expects Full Year 2024 Revenue Of $800M-$1B Versus Consensus Of $969.56M, With Combined R&D and SG&A Expenses Of $700M-$800MBenzinga Newsdesk - Feb 28, 2024, 8:09AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Feb 28, 2024, 8:06AM
- Novavax Q4 GAAP EPS $(1.44) May Not Be Comparable To $(0.45) Estimate, Sales $291.34M Miss $321.97M EstimateBenzinga Newsdesk - Feb 28, 2024, 8:02AM
- Novavax FY EPS $(5.41) Up From $(8.42) YoY, Sales $983.71M Down From $1.98B YoYBenzinga Newsdesk - Feb 28, 2024, 7:51AM
- Novavax Expects To Initiate Pivotal Phase 3 Trial For CIC Vaccine Candidate In H2 Of 2024, With Potential For Accelerated Approval And Anticipated Launch In 2026Benzinga Newsdesk - Feb 28, 2024, 7:46AM
- Novavax Says Upon Restructuring Completion Resulting Company Workforce Is Expected To Be Approximately 30% Lower As Compared To 1Q'23-EndBenzinga Newsdesk - Feb 28, 2024, 7:43AM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Thursday, February 22, 2024
- Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 22, 2024, 1:37PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Feb 22, 2024, 12:31PM
- NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Feb 22, 2024, 11:33AM
- What's Going On With Novavax Stock Today?Adam Eckert - Feb 22, 2024, 10:28AM
- Novavax shares are trading higher after the company announced it reached a settlement for its 2021 vaccine advance purchase agreement with Gavi.Benzinga Newsdesk - Feb 22, 2024, 10:28AM
- Novavax Has Reached A Settlement Related To The 2021 Advance Purchase Agreement For Novavax's Prototype Covid-19 Vaccine (NVX-COV2373)Benzinga Newsdesk - Feb 22, 2024, 6:06AM
Friday, February 09, 2024
Friday, February 02, 2024
- Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable OptionVandana Singh - Feb 2, 2024, 12:41PM
- Novavax Announced R21/Matrix-M Malaria Vaccine Phase 3 Trial Results Published In The Lancet; Reported Efficacy Of 75% When Administered Prior To The High Transmission Season: In Areas With Highly Seasonal Malaria TransmissionCharles Gross - Feb 2, 2024, 7:11AM